Benzinga | May 5, 2021 07:02AM EDT

NeoGenomics Q1 Adj. EPS $(0.04) Misses $0.01 Estimate, Sales $116.00M Beat $112.41M Estimate

NeoGenomics (NASDAQ:NEO) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.01 by 500 percent. This is a 100 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $116.00 million which beat the analyst consensus estimate of $112.41 million by 3.19 percent. This is a 9.40 percent increase over sales of $106.03 million the same period last year.